Funded Tech Companies
Caristo Diagnostics
Wondering who provided funding to Caristo Diagnostics? BioGeneration Ventures, Hadean Ventures and Forbion Capital Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Caristo Diagnostics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
New Barclay House, 234 Botley Road
Oxford, England, OX2 0HP
UK
Oxford, England, OX2 0HP
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Caristo was founded in 2018 by Cardiologists at the University of Oxford, following a decade of scientific research and technical development, to revolutionise diagnosis and treatment. With Care as one of our core values, we are committed to our mission of transforming health outcomes through clinical and scientific innovation. While we have known for over 50 years that heart attacks are caused by inflammation in coronary arteries (which supply blood to the heart), physicians have been unable to visualize and measure coronary inflammation with routine cardiac tests.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/17/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Cheng
Co-Founder
Charalambos Antoniades
Co-Founder
Cheerag Shirodaria
Company Investors
- BioGeneration Ventures
- Hadean Ventures
- Forbion Capital Partners
- Cambridge Innovation Capital
- Seroba Life Sciences
- GIMV
- Complement Therapeutics
Browse more funded tech companies:
Carisma Therapeutics | Carketa
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs